About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries
2026 Readers' Choice Winners

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

7.950 -0.240 (-2.93%)

Delayed Quote Updated: 1:52 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

May 20, 2024

Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20.

Via TheNewswire.com

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

May 20, 2024

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

Via News Direct

Immunic chief medical officer discusses promising treatments to mark World IBD Day

May 17, 2024

Immunic chief medical officer discusses promising treatments to mark World IBD Day

Via News Direct

Immunic chief medical officer discusses promising treatments to mark World IBD Day

May 17, 2024

Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19.

Via TheNewswire.com

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

May 16, 2024

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

Via News Direct

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

May 16, 2024

Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease...

Via TheNewswire.com

IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 ↗

May 08, 2024

IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Immunic's Earnings Outlook ↗

February 21, 2024

Via Benzinga

Immunic: Q3 Earnings Insights ↗

November 14, 2023

Via Benzinga

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

May 09, 2024

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

Via News Direct

Topics Intellectual Property

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

May 09, 2024

Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered,...

Via TheNewswire.com

Topics Intellectual Property

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

May 01, 2024

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Via News Direct

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

May 01, 2024

Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in...

Via TheNewswire.com

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month

March 21, 2024

--News Direct--

Via News Direct

A Preview Of Immunic's Earnings ↗

November 13, 2023

Via Benzinga

Immunic "super excited" about latest PMS trial data

October 11, 2023

--News Direct--

Via News Direct

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month

March 21, 2024

Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month,...

Via TheNewswire.com

Immunic And 2 Other Stocks Under $2 Insiders Are Buying ↗

February 29, 2024

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

What's Going On With Immunic Stock? ↗

January 05, 2024

Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 05, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 05, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

Via InvestorPlace

Immunic CSO hails "great" progress with MS program

October 24, 2023

--News Direct--

Via News Direct

Immunic CSO hails "great" progress with MS program

October 24, 2023

Immunic Inc (NASDAQ:IMUX) Chief Scientific Officer Hella Kohlhof speaks to Thomas Warner at the Proactive London after returning from MSMilan2023, the 9th Joint ECTRIMS-ACTRIMS meeting. She shares some...

Via TheNewswire.com

Immunic "super excited" about latest PMS trial data

October 11, 2023

Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced encouraging interim data from its phase II CALLIPER trial...

Via TheNewswire.com

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 10, 2023

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 10, 2023

Via Benzinga

Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate ↗

October 10, 2023

Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with

Via Benzinga

Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

October 10, 2023

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 10, 2023

It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 09, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Immunic, Inc. - Common Stock (NQ:IMUX)

All News about Immunic, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us